肠道菌群
乳酸菌
失调
代谢综合征
生物
代谢途径
脂肪变性
鼠李糖乳杆菌
代谢紊乱
新陈代谢
益生菌
微生物学
生物化学
发酵
细菌
内分泌学
肥胖
遗传学
作者
Guanchao Wang,Guangsu Zhu,C. Chen,Yi Zheng,Fangli Ma,Jianxin Zhao,Y.-K. Lee,Haihua Zhang,Wei Chen
出处
期刊:Beneficial Microbes
[Wageningen Academic Publishers]
日期:2021-06-10
卷期号:12 (3): 267-282
被引量:38
摘要
Regulation on gut microbiota and short-chain fatty acids (SCFAs) are believed to be a pathway to suppress the development of metabolic syndrome. In this study, three Lactobacillus strains derived from the human gut were investigated for their effects on alleviation of metabolic disorders. These strains were individually administered to metabolic disorder rats induced by high-fat-high-sucrose (HFHS) diet. Each strain exhibited its own characteristics in attenuating the impaired glucose-insulin homeostasis, hepatic oxidative damage and steatosis. Correlation analysis between SCFAs and host metabolic parameters suggested that Lactobacillus protective effects on metabolic disorders are partly mediated by recovery of SCFAs production, especially the faecal acetic acid. Correspondingly, it indicated that probiotics restore the gut microbiota dysbiosis in different extent, thereby protect against metabolic disorders in a manner that is associated with microbiota, but not totally reverse the changed composition of microbiota to the normal state. Thus, Lactobacillus strains partly protect against diet-induced metabolic syndrome by microbiota modulation and acetate elevation.
科研通智能强力驱动
Strongly Powered by AbleSci AI